5-(2-(5-methyl-2-phenyloxazol-4-ylmethyl)-benzofuran-5-ylmethyl)-oxazolidine-2,4-dione | 132646-45-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-(2-(5-methyl-2-phenyloxazol-4-ylmethyl)-benzofuran-5-ylmethyl)-oxazolidine-2,4-dione
• 英文别名: 5-[2-(5-methyl-2-phenyloxazol-4-ylmethyl)benzofuran-5-ylmethyl]-oxazolidine-2,4-dione；5-[2-(5-methyl-2-phenyloxazol-4-ylmethyl)benzofuran-5-ylmethyl]oxazolidine-2,4-dione；5-(2-[2-Phenyl-5-methyloxazol-4-ylmethyl]benzofur-5-ylmethyl)-2,4-oxazolidinedione；5-[[2-[(5-Methyl-2-phenyl-1,3-oxazol-4-yl)methyl]-1-benzofuran-5-yl]methyl]-1,3-oxazolidine-2,4-dione
• CAS: 132646-45-8
• 化学式: C₂₃H₁₈N₂O₅
• 分子量: 402.406
• InChiKey: KRRBFJPDQWHBRI-UHFFFAOYSA-N

物化性质

• 密度：
  1.336±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  94.6
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (5-bromo-2-benzofuranyl)(5-methyl-2-phenyl-4-oxazolyl)methane 在 palladium on activated charcoal 甲酸 、 aluminum nickel 、 氢气 、 sodium acetate 、 间氯过氧苯甲酸 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 25.0~150.0 ℃ 、275.79 kPa 条件下， 反应 24.0h， 生成 5-(2-(5-methyl-2-phenyloxazol-4-ylmethyl)-benzofuran-5-ylmethyl)-oxazolidine-2,4-dione
  参考文献：
  名称：

  Benzyloxazolidine-2,4-diones as potent hypoglycemic agents

  摘要：

  A series of benzyloxazolidine-2,4-diones, containing oxazole-based side chains, were found to lower blood glucose levels in the genetically obese ob/ob mouse. Incorporation of a benzofuran structural element in these compounds provides greatly enhanced in vivo potency. The syntheses and structure-activity relationships for this series are detailed.

  DOI：

  10.1021/jm00109a003

文献信息

• Method of inhibiting angiogenesis
  申请人：Genentech, Inc.

  公开号：US20010036955A1

  公开（公告）日：2001-11-01

  Angiogenesis is inhibited and the growth of tumors is treated by administering an effective amount of a PPAR gamma ligand/agonist, optionally with an RXR receptor ligand.

  血管生成受到抑制，肿瘤生长通过给予有效剂量的PPARγ配体/激动剂进行治疗，可选地与RXR受体配体一起使用。
• Neovascularization inhibitors
  申请人：——

  公开号：US20030134884A1

  公开（公告）日：2003-07-17

  An angiogenesis inhibitor containing a compound represented by the formula 1 wherein R 4 is an optionally substituted hydrocarbon group and the like; Xa is a bond and the like; k is an integer of 1 to 3; Ya is an oxygen atom and the like; ring Ea is a benzene ring optionally having additional substituent(s); p is an integer of 1 to 8; R 5 is a hydrogen atom and the like; q is an integer of 0 to 6; r is 0 or 1; R 8 is a hydroxy group and the like; and R 6 and R 7 are hydrogen atoms and the like, or a salt thereof is useful as an agent for the prophylaxis or treatment of tumor and the like.

  一种含有由下式表示的化合物的血管生成抑制剂 其中R4是可选择地取代的碳氢基团等；Xa是键等；k是1到3的整数；Ya是氧原子等；环Ea是苯环，可选择地具有额外的取代基；p是1到8的整数；R5是氢原子等；q是0到6的整数；r为0或1；R8是羟基等；R6和R7是氢原子等，或其盐，可用作预防或治疗肿瘤等的药剂。
• Oxazolidinedione hypoglycemic agents
  申请人：Pfizer Inc.

  公开号：US05498621A1

  公开（公告）日：1996-03-12

  Compounds of the formulae ##STR1## where R is cycloalkyl or aryl; R.sub.1 is alkyl, X is O or C.dbd.O; A is O or S; and B is N or CH are useful as hypoglycemic agents.

  式##STR1##中R为环烷基或芳基；R.sub.1为烷基，X为O或C.dbd.O；A为O或S；B为N或CH的化合物可用作降糖药。
• Abc expression promoters
  申请人：——

  公开号：US20040077689A1

  公开（公告）日：2004-04-22

  The ABCA1 mRNA expression-promoting agent, LXR&agr; mRNA expression-promoting agent, ABCG1 mRNA expression-promoting agent, cholesterol efflux-promoting agent, cholesteryl ester accumulation-inhibiting agent, ACAT-1 mRNA expression-inhibiting agent and CEH mRNA expression-promoting agent of the present invention are excellent in the ability to control cholesterol distribution in the body and have low toxicity.

  本发明的ABCA1 mRNA表达促进剂、LXRα mRNA表达促进剂、ABCG1 mRNA表达促进剂、胆固醇外流促进剂、胆固醇酯积聚抑制剂、ACAT-1 mRNA表达抑制剂和CEH mRNA表达促进剂在控制体内胆固醇分布方面具有出色的能力和低毒性。
• Fluorescent substrates for detecting organophosphatase enzyme activity
  申请人：Soukharev Serguei

  公开号：US20070042370A1

  公开（公告）日：2007-02-22

  Disclosed are compounds of the formula (I): wherein R 3 , R 4 , R 5 , R 9 , and R 10 are selected from the group consisting of H and groups or atoms other than H, and R 6 and R 8 are halo or hydrogen; X 1 , X 2 , and X 3 are independently O or S; provided that R 9 and R 10 are not simultaneously H, when all of X 1 , X 2 , and X 3 are O; and of the formula (II) wherein R 11 -R 14 are selected from the group consisting of H and groups or atoms other than H; X 4 -X 9 are independently O or S; n and m are 0 or 1 but m and n cannot be 0 simultaneously; R 15 -R 24 can be H or any substituent so long as the compound of formula II upon hydrolysis provides a fluorescent compound. These compounds are useful as substrates with high specificity for organophosphatase particularly human paraoxonase and bacterial organophosphorus hydrolase. Also disclosed is a method for detecting and/or measuring the paraoxonase activity in a fluid comprising contacting the fluid with a fluorescent substrate and measuring the fluorescence of the fluorescent product formed.

  本发明涉及式(I)的化合物：其中R3、R4、R5、R9和R10选自H和除H以外的基团或原子，而R6和R8是卤素或氢；X1、X2和X3独立地是O或S；前提是当X1、X2和X3全为O时，R9和R10不能同时是H；以及式(II)的化合物：其中R11-R14选自H和除H以外的基团或原子；X4-X9独立地是O或S；n和m为0或1，但m和n不能同时为0；R15-R24可以是H或任何取代基，只要式II的化合物在水解后提供荧光化合物即可。这些化合物可用作具有高特异性的有机磷酸酯酶底物，特别是人类副氧化物酶和细菌有机磷酸酯水解酶。本发明还涉及一种检测和/或测量液体中副氧化物酶活性的方法，包括将液体与荧光底物接触，并测量形成的荧光产物的荧光强度。